Welcome to Insider Healthcare. I’m Lydia Ramsey Pflanzer, and today in healthcare news:
- Novavax’s coronavirus vaccine is 90% effective at preventing COVID-19;
- The CDC is investigating whether there’s a link between coronavirus shots and rare cases of heart inflammation in young people;
- Biden’s $400 billion home-care plan is in jeopardy.
Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use
- Novavax said its coronavirus vaccine was 90% effective at preventing COVID-19.
- The shot succeeded in a study that enrolled almost 30,000 volunteers in the US and Mexico.
- The Maryland biotech plans to ask US regulators for permission to give the shot more widely.
Young people are experiencing rare cases of heart inflammation after getting coronavirus vaccines, but doctors say the risk of COVID-19 is far greater
- Young people who got COVID-19 vaccines have reported higher rates of heart inflammation.
- The CDC is investigating whether there’s a link between the Pfizer and Moderna shots and these events.
- Even if there is a link, doctors said, the risk from COVID-19 is far greater than from the vaccines.
Biden’s plan to send $400 billion to help families caring for loved ones with disabilities is in jeopardy as infrastructure talks falter
- More than 820,000 people, most with developmental disabilities, are on waiting lists for home care.
- Biden wants Congress to allow $400 billion for home care to help cut the wait, which can last years.
- Republicans oppose having it in an infrastructure bill, and it’s unclear how far Democrats will go.
More stories we’re reading:
- Hormone replacement therapy can cause dry skin and acne in trans people, but the right skin care routine can combat side effects (Insider)
- How hospitals are using predatory billing practices and driving up costs for patients (Axios)
- 2 varieties of flu seem to have disappeared during lockdown. Experts say it’s possible they’re gone. (Insider)
- A biotech bets big on a non-hormonal contraceptive gel (The New York Times)